Fletcher Taylor

Summary

Affiliation: Rainier Associates
Country: USA

Publications

  1. ncbi Propranolol for reemergent posttraumatic stress disorder following an event of retraumatization: a case study
    Fletcher Taylor
    Rainier Associates, Tacoma, Washington 98467, USA
    J Trauma Stress 15:433-7. 2002
  2. ncbi The efficacy of nefazodone augmentation for treatment-resistant depression with anxiety symptoms or anxiety disorder
    Fletcher B Taylor
    Rainier Associates, Tacoma, Washington 98467, USA
    Depress Anxiety 18:83-8. 2003
  3. ncbi Tiagabine for posttraumatic stress disorder: a case series of 7 women
    Fletcher B Taylor
    Rainier Associates, Tacoma, WA 98467, USA
    J Clin Psychiatry 64:1421-5. 2003
  4. ncbi Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder
    Fletcher B Taylor
    Rainier Associates, Tacoma, Washington 98467, USA
    Biol Psychiatry 59:577-81. 2006
  5. ncbi The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder
    Fletcher Taylor
    Rainier Associates, Tacoma, WA 98467, USA
    J Clin Psychopharmacol 22:82-5. 2002
  6. ncbi Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study
    Fletcher B Taylor
    Northwest Network VISN 20 Mental Illness Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington 98108, USA
    Biol Psychiatry 63:629-32. 2008
  7. ncbi Nonnightmare distressed awakenings in veterans with posttraumatic stress disorder: response to prazosin
    Charles E Thompson
    VA Northwest Network, Mental Illness Research, Education and Clinical Center, Seattle, WA 98108, USA
    J Trauma Stress 21:417-20. 2008
  8. ncbi Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans
    Bernd Jilma
    Department of Clinical Pharmacology, Vienna University, Vienna, Austria
    Clin Pharmacol Ther 72:403-10. 2002
  9. ncbi A retrospective chart review of the effects of modafinil on depression as monotherapy and as adjunctive therapy
    Charles S Price
    Department of Psychiatry, University of Nevada, Reno, NV, USA
    Depress Anxiety 21:149-53. 2005

Collaborators

Detail Information

Publications9

  1. ncbi Propranolol for reemergent posttraumatic stress disorder following an event of retraumatization: a case study
    Fletcher Taylor
    Rainier Associates, Tacoma, Washington 98467, USA
    J Trauma Stress 15:433-7. 2002
    ..To our knowledge, this is the first report of the effects of propranolol treatment on reemergent PTSD symptoms. Propranolol may be particularly efficacious in the prevention of initial or reemergent PTSD symptoms...
  2. ncbi The efficacy of nefazodone augmentation for treatment-resistant depression with anxiety symptoms or anxiety disorder
    Fletcher B Taylor
    Rainier Associates, Tacoma, Washington 98467, USA
    Depress Anxiety 18:83-8. 2003
    ..The mean effective dose for nefazodone (mean+/-sd) was 200.0 (34.2) mg a day (range 50-300 mg a day). Nefazodone's unique pharmacologic profile may explain its unusual efficacy in these cases of treatment-resistant major depression...
  3. ncbi Tiagabine for posttraumatic stress disorder: a case series of 7 women
    Fletcher B Taylor
    Rainier Associates, Tacoma, WA 98467, USA
    J Clin Psychiatry 64:1421-5. 2003
    ..Tiagabine, a selective GABA reuptake inhibitor, was evaluated as a treatment for PTSD...
  4. ncbi Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder
    Fletcher B Taylor
    Rainier Associates, Tacoma, Washington 98467, USA
    Biol Psychiatry 59:577-81. 2006
    ..This study addressed whether daytime prazosin compared to placebo would alleviate psychological distress provoked experimentally by a trauma-related word list included in the emotional Stroop (E-Stroop) paradigm...
  5. ncbi The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder
    Fletcher Taylor
    Rainier Associates, Tacoma, WA 98467, USA
    J Clin Psychopharmacol 22:82-5. 2002
    ..The drug was reasonably tolerated, and there were no drug discontinuations. These preliminary findings provide a rationale for blind placebo-controlled efficacy trials of the alpha 1 antagonist prazosin for PTSD...
  6. ncbi Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study
    Fletcher B Taylor
    Northwest Network VISN 20 Mental Illness Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington 98108, USA
    Biol Psychiatry 63:629-32. 2008
    ..We evaluated objective sleep parameters and PTSD symptoms in a placebo-controlled prazosin trial for civilian trauma-related PTSD...
  7. ncbi Nonnightmare distressed awakenings in veterans with posttraumatic stress disorder: response to prazosin
    Charles E Thompson
    VA Northwest Network, Mental Illness Research, Education and Clinical Center, Seattle, WA 98108, USA
    J Trauma Stress 21:417-20. 2008
    ..6 to 2.2, NNDA from 5.2 to 2.1, and sleep difficulty from 7.2 to 4.1 per week. These results suggest that increased brain adrenergic activity may contribute to the pathophysiology of both trauma-related nightmares and NNDA in PTSD...
  8. ncbi Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans
    Bernd Jilma
    Department of Clinical Pharmacology, Vienna University, Vienna, Austria
    Clin Pharmacol Ther 72:403-10. 2002
    ..This lethal animal model suggested that tissue factor also influences inflammatory cascades...
  9. ncbi A retrospective chart review of the effects of modafinil on depression as monotherapy and as adjunctive therapy
    Charles S Price
    Department of Psychiatry, University of Nevada, Reno, NV, USA
    Depress Anxiety 21:149-53. 2005
    ..This chart review provides preliminary evidence that modafinil treatment may be beneficial to those with major depression, even when unresponsive to other treatments...